On what evidence-base do we recommend self-monitoring of blood glucose?

Diabetes Research and Clinical Practice

Volumn 87, Issue 2, 2010, Pages 150-156

  Kolb, Hubert ^a   Kempf, Kerstin ^b   Martin, Stephan ^b   Stumvoll, Michael ^c   Landgraf, Rüdiger ^d  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b SANA KLINIKUM OFFENBACH   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d German Diabetes Foundation   (Germany)

Author keywords

Gestational diabetes; HbA1c; Hypoglycaemia; Self monitoring of blood glucose; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLICLAZIDE; GLITAZONE DERIVATIVE; GLUCOSE; INSULIN; METFORMIN; SULFONYLUREA;

BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DIABETES MELLITUS; DIET THERAPY; DRUG DOSE ESCALATION; EVIDENCE BASED MEDICINE; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL COUNSELING; PREGNANCY DIABETES MELLITUS; REVIEW; SELF MONITORING;

ACTIVITIES OF DAILY LIVING; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; EVIDENCE-BASED MEDICINE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 74849129230     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.10.014     Document Type: Review

References (77)

1. Worth R., Home P.D., Johnston D.G., Anderson J., Ashworth L., Burrin J.M., et al. Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br. Med. J. (Clin. Res. Ed.) 285 (1982) 1233-1240
2. Miller P.F., Stratton C., and Tripp J.H. Blood testing compared with urine testing in the long term control of diabetes. Arch. Dis. Child 58 (1983) 294-297
3. Mann N.P., Noronha J.L., and Johnston D.I. A prospective study to evaluate the benefits of long-term self-monitoring of blood glucose in diabetic children. Diabetes Care 7 (1984) 322-326
4. Daneman D., Siminerio L., Transue D., Betschart J., Drash A., and Becker D. The role of self-monitoring of blood glucose in the routine management of children with insulin-dependent diabetes mellitus. Diabetes Care 8 (1985) 1-4
5. Terent A., Hagfall O., and Cederholm U. The effect of education and self-monitoring of blood glucose on glycosylated hemoglobin in type I diabetes. A controlled 18-month trial in a representative population. Acta Med. Scand. 217 (1985) 47-53
6. Gordon D., Semple C.G., and Paterson K.R. Do different frequencies of self-monitoring of blood glucose influence control in type 1 diabetic patients?. Diabet. Med. 8 (1991) 679-682
7. Starostina E.G., Antsiferov M., Galstyan G.R., Trautner C., Jorgens V., Bott U., et al. Effectiveness cost-benefit analysis of intensive treatment and teaching programmes for type 1 (insulin-dependent) diabetes mellitus in Moscow - blood glucose versus urine glucose self-monitoring. Diabetologia 37 (1994) 170-176
8. Carney R.M., Schechter K., Homa M., Levandoski L., White N., and Santiago J. The effects of blood glucose testing versus urine sugar testing on the metabolic control of insulin-dependent diabetic children. Diabetes Care 6 (1983) 378-380
9. Muhlhauser I., Bruckner I., Berger M., Cheta D., Jorgens V., Ionescu-Tirgoviste C., et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Dusseldorf Study. Diabetologia 30 (1987) 681-690
10. Pieber T.R., Brunner G.A., Schnedl W.J., Schattenberg S., Kaufmann P., and Krejs G.J. Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 18 (1995) 625-630
11. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. Br. Med. J. 325 (2002) 746
12. DAFNE Study Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329 (1993) 977-986
13. Reichard P., Nilsson B.Y., and Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N. Engl. J. Med. 329 (1993) 304-309
14. Kapoor N., Sankaran S., Hyer S., and Shehata H. Diabetes in pregnancy: a review of current evidence. Curr. Opin. Obstet. Gynecol. 19 (2007) 586-590
15. Landon M.B., Gabbe S.G., Piana R., Mennuti M.T., and Main E.K. Neonatal morbidity in pregnancy complicated by diabetes mellitus: predictive value of maternal glycemic profiles. Am. J. Obstet. Gynecol. 156 (1987) 1089-1095
16. Langer O., Levy J., Brustman L., Anyaegbunam A., Merkatz R., and Divon M. Glycemic control in gestational diabetes mellitus - how tight is tight enough: small for gestational age versus large for gestational age?. Am. J. Obstet. Gynecol. 161 (1989) 646-653
17. Jensen D.M., Damm P., Moelsted-Pedersen L., Ovesen P., Westergaard J.G., Moeller M., et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 27 (2004) 2819-2823
18. Lapolla A., Dalfra M.G., Bonomo M., Castiglioni M.T., Di Cianni G., Masin M., et al. Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels?. Diabetes Res. Clin. Pract. 77 (2007) 465-470
19. Metzger B.E., Lowe L.P., Dyer A.R., Trimble E.R., Chaovarindr U., Coustan D.R., et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358 (2008) 1991-2002
20. Crowther C.A., Hiller J.E., Moss J.R., McPhee A.J., Jeffries W.S., and Robinson J.S. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 352 (2005) 2477-2486
21. Kinsley B. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus. Clin. Ther. 29 Suppl D (2007) S153-S160
22. Nicholson W.K., Wilson L.M., Witkop C.T., Baptiste-Roberts K., Bennett W.L., Bolen S., et al. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Evid. Rep. Technol. Assess. (Full. Rep.) (2008) 1-96
23. Hanson U., Persson B., Enochsson E., Lennerhagen P., Lindgren F., Lundstrom V., et al. Self-monitoring of blood glucose by diabetic women during the third trimester of pregnancy. Am. J. Obstet. Gynecol. 150 (1984) 817-821
24. Stubbs S.M., Brudenell J.M., Pyke D.A., Watkins P.J., Stubbs W.A., and Alberti K.G. Management of the pregnant diabetic: home or hospital, with or without glucose meters?. Lancet 1 (1980) 1122-1124
25. Goldberg J.D., Franklin B., Lasser D., Jornsay D.L., Hausknecht R.U., Ginsberg-Fellner F., et al. Gestational diabetes: impact of home glucose monitoring on neonatal birth weight. Am. J. Obstet. Gynecol. 154 (1986) 546-550
26. Varner M.W. Efficacy of home glucose monitoring in diabetic pregnancy. Am. J. Med. 75 (1983) 592-596
27. de Veciana M., Major C.A., Morgan M.A., Asrat T., Toohey J.S., Lien J.M., et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N. Engl. J. Med. 333 (1995) 1237-1241
28. Homko C.J., Sivan E., and Reece E.A. The impact of self-monitoring of blood glucose on self-efficacy and pregnancy outcomes in women with diet-controlled gestational diabetes. Diabetes Educ. 28 (2002) 435-443
29. Murphy H.R., Rayman G., Lewis K., Kelly S., Johal B., Duffield K., et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. Br. Med. J. 337 (2008) a1680
30. Schaefer-Graf U.M., Kjos S.L., Fauzan O.H., Buhling K.J., Siebert G., Buhrer C., et al. A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care 27 (2004) 297-302
31. Wing R.R., Epstein L.H., Nowalk M.P., Scott N., Koeske R., and Hagg S. Does self-monitoring of blood glucose levels improve dietary compliance for obese patients with type II diabetes?. Am. J. Med. 81 (1986) 830-836
32. Fontbonne A., Billault B., Acosta M., Percheron C., Varenne P., Besse A., et al. Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabetes Metab. 15 (1989) 255-260
33. Allen B.T., DeLong E.R., and Feussner J.R. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing. Diabetes Care 13 (1990) 1044-1050
34. Estey A.L., Tan M.H., and Mann K. Follow-up intervention: its effect on compliance behavior to a diabetes regimen. Diabetes Educ. 16 (1990) 291-295
35. Rutten G., van Eijk J., de Nobel E., Beek M., and van der Helden H. Feasibility and effects of a diabetes type II protocol with blood glucose self-monitoring in general practice. Fam. Pract. 7 (1990) 273-278
36. Muchmore D.B., Springer J., and Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol. 31 (1994) 215-219
37. Jaber L.A., Halapy H., Fernet M., Tummalapalli S., and Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann. Pharmacother. 30 (1996) 238-243
38. Miles P., Everett J., Murphy J., and Kerr D. Comparison of blood or urine testing by patients with newly diagnosed non-insulin dependent diabetes: patient survey after randomised crossover trial. Br. Med. J. 315 (1997) 348-349
39. Kibriya M.G., Ali L., Banik N.G., and Khan A.K. Home monitoring of blood glucose (HMBG) in type-2 diabetes mellitus in a developing country. Diabetes Res. Clin. Pract. 46 (1999) 253-257
40. Brown S.A., Garcia A.A., Kouzekanani K., and Hanis C.L. Culturally competent diabetes self-management education for Mexican Americans: the Starr County border health initiative. Diabetes Care 25 (2002) 259-268
41. Guerci B., Drouin P., Grange V., Bougneres P., Fontaine P., Kerlan V., et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab. 29 (2003) 587-594
42. Jones H., Edwards L., Vallis T.M., Ruggiero L., Rossi S.R., Rossi J.S., et al. Changes in diabetes self-care behaviors make a difference in glycemic control: the Diabetes Stages of Change (DiSC) study. Diabetes Care 26 (2003) 732-737
43. Kwon H.S., Cho J.H., Kim H.S., Song B.R., Ko S.H., Lee J.M., et al. Establishment of blood glucose monitoring system using the Internet. Diabetes Care 27 (2004) 478-483
44. Cho J.H., Chang S.A., Kwon H.S., Choi Y.H., Ko S.H., Moon S.D., et al. Long-term effect of the Internet-based glucose monitoring system on HbA1c reduction and glucose stability: a 30-month follow-up study for diabetes management with a ubiquitous medical care system. Diabetes Care 29 (2006) 2625-2631
45. Johnson J.A., Majumdar S.R., Bowker S.L., Toth E.L., and Edwards A. Self-monitoring in Type 2 diabetes: a randomized trial of reimbursement policy. Diabet. Med. 23 (2006) 1247-1251
46. Moreland E.C., Volkening L.K., Lawlor M.T., Chalmers K.A., Anderson B.J., and Laffel L.M. Use of a blood glucose monitoring manual to enhance monitoring adherence in adults with diabetes: a randomized controlled trial. Arch. Intern. Med. 166 (2006) 689-695
47. Siebolds M., Gaedeke O., and Schwedes U. Self-monitoring of blood glucose - psychological aspects relevant to changes in HbA1c in type 2 diabetic patients treated with diet or diet plus oral antidiabetic medication. Patient Educ. Couns. 62 (2006) 104-110
48. Simon J., Gray A., Clarke P., Wade A., Neil A., and Farmer A. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. Br. Med. J. 336 (2008) 1177-1180
49. Farmer A.J., Wade A.N., French D.P., Simon J., Yudkin P., Gray A., et al. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. Health Technol. Assess. 13 (2009) iii-xi, 1
50. Scherbaum W.A., Ohmann C., Abholz H.H., Dragano N., and Lankisch M. Effect of the frequency of self-monitoring blood glucose in patients with type 2 diabetes treated with oral antidiabetic drugs-a multi-centre, randomized controlled trial. PLoS One 3 (2008) e3087
51. Davidson M.B., Castellanos M., Kain D., and Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am. J. Med. 118 (2005) 422-425
52. Farmer A., Wade A., Goyder E., Yudkin P., French D., Craven A., et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. Br. Med. J. 335 (2007) 132
53. O'Kane M.J., Bunting B., Copeland M., and Coates V.E. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. Br. Med. J. 336 (2008) 1174-1177
54. Schwedes U., Siebolds M., and Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 25 (2002) 1928-1932
55. Barnett A.H., Krentz A.J., Strojek K., Sieradzki J., Azizi F., Embong M., et al. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes. Metab. 10 (2008) 1239-1247
56. Bergenstal R.M., and Gavin III J.R. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am. J. Med. 118 (2005) 1S-6S
57. Peter R., Okoseime O.E., Rees A., and Owens D.R. Postprandial glucose - a potential therapeutic target to reduce cardiovascular mortality. Curr. Vasc. Pharmacol. 7 (2009) 68-74
58. Davidson M.B. Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care 28 (2005) 1531-1533
59. Ceriello A., and Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Diabet. Med. 25 (2008) 1151-1156
60. Kempf K., Neukirchen W., Martin S., and Kolb H. Self-monitoring of blood glucose in type 2 diabetes: a new look at published trials. Diabetologia 51 (2008) 686-688
61. McAndrew L., Schneider S.H., Burns E., and Leventhal H. Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educ. 33 (2007) 991-1011
62. McGeoch G., Derry S., and Moore R.A. Self-monitoring of blood glucose in type-2 diabetes: what is the evidence?. Diabetes Metab. Res. Rev. 23 (2007) 423-440
63. Poolsup N., Suksomboon N., and Jiamsathit W. Systematic review of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients. Diabetes Technol. Ther. 10 Suppl. 1 (2009) S-51-S-66
64. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 837-853
65. UKPDS Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 854-865
66. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br. Med. J. 321 (2000) 405-412
67. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28 (1995) 103-117
68. Shichiri M., Kishikawa H., Ohkubo Y., and Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23 Suppl 2 (2000) B21-B29
69. ADVANCE Collaborative Group, Patel A., MacMahon S., Chalmers J., Neal B., Billot L., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358 (2008) 2560-2572
70. Del Prato S. Megatrials in type 2 diabetes. From excitement to frustration?. Diabetologia 52 (2009) 1219-1226
71. Ray K.K., Seshasai S.R., Wijesuriya S., Sivakumaran R., Nethercott S., Preiss D., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373 (2009) 1765-1772
72. Donnelly L.A., Morris A.D., Frier B.M., Ellis J.D., Donnan P.T., Durrant R., et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet. Med. 22 (2005) 749-755
73. Cryer P.E. The barrier of hypoglycemia in diabetes. Diabetes 57 (2008) 3169-3176
74. Amiel S.A., Dixon T., Mann R., and Jameson K. Hypoglycaemia in type 2 diabetes. Diabet. Med. 25 (2008) 245-254
75. Whitmer R.A., Karter A.J., Yaffe K., Quesenberry Jr. C.P., and Selby J.V. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301 (2009) 1565-1572
76. Nathan D.M., Cleary P.A., Backlund J.Y., Genuth S.M., Lachin J.M., Orchard T.J., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353 (2005) 2643-2653
77. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., and Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359 (2008) 1577-1589